Oxidative injury and potential use of antioxidants in schizophrenia

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 1-2, 1996, Pages 45-54

  Mahadik, S P ^a,b   Scheffer, R E ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Dwight David Eisenhower Army Med C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FATTY ACID; MEMBRANE PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

CONFERENCE PAPER; ERYTHROCYTE; HUMAN; LIPID METABOLISM; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0029742374     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90144-1     Document Type: Conference Paper

References (117)

1. Burton G. W., Ingold K. U. Mechanisms of antioxidant action: preventive and chain-breaking antioxidants. In: Miguel A., Quintanilha A. T., Weber H., eds. CRC Handbook of Free Radicals and Antioxidants in Biomedicine. Vol II. Boca Raton: CRC Press Inc., 1990; pp 29-43.
2. Fridovich I. Superoxide dismutase. Annu Rev Biochem 1975; 44: 147-159.
3. Fridovich I. Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol 1983; 23: 239-257.
4. Halliwell B. Biochemical mechanisms accounting for the toxic action of oxygen on living organisms: the key role of superoxide dismutase. Cell Biol Int Rep 1978; 2: 113-128.
5. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609-1623.
6. Halliwell B., Gutteridge J. M. C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 1-14.
7. Halliwell B., Gutteridge J. M. C. Oxygen radicals and the nervous system. TINS 1985; 8: 22-26.
8. Halliwell B., Gutteridge J. M. C. Antioxidants of human extracellular fluids. Arch Biochem Biophys 1990; 280: 1-8
9. Wolff S. P., Dean R. T. Fragmentation of proteins by free radicals and its effect on their susceptibility to enzymic hydrolysis. Biochem J 1986; 234: 399-403.
10. Stadtman E. R. Protein oxidation and aging. Science 1992; 257: 1220-1224.
11. 2 with unsaturated fatty acids. J Biol Chem 1983; 258: 4759-4761.
12. Gutteridge J. M. C. Lipid peroxidation: some problems and concepts. In: Halliwell B., ed. Oxygen Radicals and Tissue Injury. Proc Upjohn Symposium. Rockville Bethesda: FASEB Press, 1988; pp 9-19.
13. Mellow-Filho A. C., Meneghini R. In vivo formation of single strand breaks in DNA by hydrogen peroxide is mediated by the Haber-Weiss reaction. Biochim Biophys Acta 1984; 781: 56-63.
14. Ames B. A., Shingenaga M. K., Park E-M. Oxyradicals and DNA damage. In: Davies K. J. A., ed. Oxidation Damage and Repair: Chemical, Biological and Medical Aspects. New York: Pergamon Press, 1991; pp 181-187.
15. Cadet J. L., Lohr J. B. Free radicals and the developmental pathobiology of schizophrenic burnout. Integr Psychiatr 1987; 5: 40-48.
16. Nohl H., Breuninger V., Hegner D. Influence of rnitochondrial radical formation of energy-linked respiration. Eur J Biochem 1978; 90: 385-390.
17. Fried R., Mandel P. Superoxide dismutase of mammalian nervous system. J Neurochem 1975; 24: 433-438.
18. Borg D. C., Schaich K. M. Iron and iron-derived radicals. In: Halliwell B., ed. Free Radicals and Tissue Injury. Proc Upjohn Symposia. Bethesda: FASEB Press Rockville, 1988; pp 20-26.
19. Garthwaite J. Glutamate nitric oxide and cell-cell signalling in the nervous system. TINS 1991; 14: 60-67.
20. Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide physiology pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
21. Radi R., Beckman J. S., Bush K. M., Freeman B. A. Peroxinitrite oxidation of sufhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266: 4244-4250.
22. Burton G. W., Ingold K. U. Vitamin E as an in vitro and in vivo antioxidant Ann NY Acad Sci 1989; 570: 7-22.
23. Mavelli I., Rigo A., Federico R., Ciriolo M. R., Rotilio G. Superoxide dismutase glutathione peroxidase and catalase in developing rat brain. Biochem J 1982; 204: 535-540.
24. Scarpa M., Rigo A., Viglino P., Stevanato R., Bracco F., Battistin L. Age dependence of the levels of the enzymes involved in the protection against active oxygen species in the rat brain. Proc Soc Expt Biol Med 1987; 185: 129-135.
25. Dionisi O., Galeotti T., Terranva T., Azzi A. Superoxide radicals and hydrogen peroxide formation in mitochondrial from normal and neoplastic tissues. Biochim Biophys Acta 1975; 403: 292-300.
26. Fisher A. B. Intracellular production of oxygen-derived free radicals. In: Halliwell B., ed. Free Radicals and Tissue Injury. Proc Upjohn Symposia. Rockville Bethesda: FASEB Press, 1988; pp 34-42.
27. Vitorica J., Machado A., Satrustegui J. Age-dependent variations in peroxide-utilizing enzymes from rat brain mitochondrial and cytoplasm. J Neurochem 1984; 42: 351-356.
28. Cohen G., Hochstein P. Glutathione peroxidase: The primary agent for the elimination of hydrogen peroxide in erythrocytes. Biochemistry 1963; 2: 1420-1428.
29. Prohaska J. R., Ganther H. E. Selenium and glutathione peroxidase in developing rat brain. J Neurochem 1976; 27: 1379-1387
30. Savolainen H. Superoxide dismutase and glutathione peroxidase activities in rat brain. Res Commun Chem Pathol Pharmacol 1978; 21: 173-176.
31. Brannan T. S., Maker H. S., Weiss C., Cohen G. Regional distribtuion of glutathione peroxidase in the adult rat brain. J Neurochem 1980; 35: 1013-1014.
32. Cohen G., Greenwald R. A., eds. Oxyradicals and Their Scavenger Systems. Vol. 1. Molecular Aspects. Proc Third Int Conf on Superoxide and Superoxide Dismutase. New York: Elsevier Publishing Co Inc, 1983.
33. Ames B. N., Cathcart R., Schwier E., Hochstein P. Uric acid an antioxidant in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-6862.
34. Frei B., England L., Ames B. N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989; 86: 6377-6381.
35. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
36. Janero D. R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biol Med 1990; 9: 515-540.
37. Young I. S., Trimble E. R. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991; 28: 504-508.
38. Gutteridge J. M. C. The role of superoxide and hydroxyl radicals in phospholipid peroxidation catalysed by iron salts. FEBS Lett 1982; 150: 454-458.
39. MacGee J. Enzymatic determination of polyunsaturated fatty acids. Anal Chem 1959; 31: 298-302.
40. Haugard N. Cellular mechanisms of oxygen toxicity. Physiol Rev 1968; 48: 311-345.
41. Levine R. L., Garland D., Oliver C. N. et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478.
42. Allen R. G., Balin A. K. Oxidative influence on development and differentiation: an overview of a free radical theory of development. Free Radical Biol Med 1989; 6: 631-661.
43. Kuksis A. Fatty acid composition of glycerolipids of animal tissues. In: Kuksis A., ed. Handbook of Lipid Research. Vol 1. New York: Pergamon Press, 1978; pp 381-441.
44. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298-300.
45. Axelrod J. Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. Biochem Soc Trans 1990; 18: 503-507.
46. Dennis E. A., Rhee S. G., Billah M. M., Hannum Y. A. Role of phospholipase in generating lipid second messenger signal transduction. FASEB J 1991; 5: 2068-2077.
47. Farooqui A. A., Hirashima Y., Horrocks L. A. Brain phospholipases and their role in signal transduction. In: Bazan N. G., Toffano G., Horrobin D. F., eds. Neurobiology of Essential Fatty Acids. New York: Plenum Press, 1992; pp 11-25.
48. Rafalowska U., Liu G-J., Floyd R. A. Peroxidation induced changes in synaptosomal transport of dopamine and - aminobutyric acid. Free Radical Biol Medicine 1989; 6: 485-492.
49. Schwartz R. D., Skolnick P., Paul S. M. Regulation of γ-aminobutyric acid/barbiturate receptor gated chloride ion flux in brain vesicles by phospholipase A2: Possible role of oxygen radicals. J Neurochem 1988; 50: 565-571.
50. Pall H. S., Williams A. C., Blake D. R., Lunec J. Evidence of enhanced lipid peroxidation in cerebrospinal fluid of patients taking phenothiazines. Lancet 1987; 2: 596-599.
51. Lohr J. B., Underbill S., Moir S., Jeste D. V. Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiatr 1990; 28: 535-539.
52. Peet M., Laugharne J., Rangarajan N., Renolds G. P. Tardive dyskinesia, lipid peroxidation and sustained amelioration with vitamin E treatment. Int Clin Psychopharmacol 1993; 8: 151-153.
53. McCreadie R. G., MacDonald E., Wiles D., Campbell G., Paterson J. R. The nithsdale schizophrenia surveys XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia and in normal subjects. Br J Psychiatr 1995; 167: 1-8.
54. Mahadik S. P., Mukherjee S., Correnti E. E., Scheffer R. Elevated levels of lipid peroxidation products in plasma from drug-naive patient at the onset of psychosis Schizophr Res 1995; 15: 66.
55. Rotrosen J., Wolkin A. Phospholipid and prostaglandin hypotheses of schizophrenia. In: Meltzer H. Y., ed. Psychopharmacology: The Third Generation of Progress. New York: Raven Press, 1987; pp 759-764.
56. Keshavan M. S., Mallinger A. G., Pettegrew J. W., Dippold C. Erythrocyte membrane phospholipids in psychotic patients. Psychiatr Res 1993; 49: 89-95.
57. Mahadik S. P., Mukherjee S., Correnti E. et al. Distribution of plasma membrane phospholipids and cholesterol in skin fibroblasts from drug-naive patients at the onset of psychosis. Schizophr Res 1994; 13: 239-247.
58. Vaddadi K. S., Courtney P., Gilleard C. S., Manku M. S., Horrobin D. F. A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia. Psychiatr 1989; 27: 313-323.
59. Glen A. I. M., Glen E. M. T., Horrobin D. F. et al. A red cell membrane abnormality in a subgroup of schizophrenic patients: Evidence for two diseases. Schizophr Res 1994; 12: 53-61.
60. Mukherjee S., Mahadik S. P., Horrobin D. F., Jenkins K., Correnti E., Scheffer R. Membrane fatty acid composition of fibroblasts from schizophrenic patients. Biol Psychiatr 1994; 35: 700.
61. Yao J. K., van Kammen D. P., Welker J. A., Gurklis J. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition. Schizophr Res 1994; 13: 217-226.
62. Horrobin D. F., Manku M. S., Hillman S., Glen I. A. M. Fatty acid levels in brains of schizophrenics and normal controls. Biol Psychiatr 1991; 30: 795-805.
63. Lohr J. B., Cadet J. L., Lohr M. A., Jeste D. V., Wyatt R. J. Alpha-tocopherol in tardive dyskinesia. Lancet 1987; 1: 913-914.
64. Lohr J. B., Cadet J. L., Lohr M. A. et al. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanism. Schizophr Bull 1988; 14: 291-296.
65. Scapicchio P., Decina P., Mukherjee S., Caracci G. Effects of α-tocopherol on persistent tardive dyskinesia in elderly schizophrenic patients. Ital J Psych Behav Sci 1991; 1: 111-114.
66. Egan M. T., Hyde T. M., Albers G. W. et al. Treatment of tardive dyskinesia with vitamin E. Am J Psychiatr 1992; 149: 773-777
67. Adler L. A., Peselo E., Rotrosen J. et al. Vitamin E treatment of tardive dyskinesia. Am J Psychiatr 1993; 150: 1405-1407.
68. Golse B., Debray Q., Puget K., Michelson A. M. Dosages erythrocytaires de la superoxyde dismutases 1 et de la glutathion peroxydase dans les schizophrenies de líadulte. Nouv Pr Med 1978; 7: 2070-2071.
69. Abdalla D. S. P., Manteiro H. P., Olivera J. A. C., Bechara C. H. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic depressive patients. Clin Chem 1986; 32: 805-807.
70. Reddy R., Mahadik S. P., Mukherjee S., Murthy J. N. Enzymes of the antioxidant defense system in chronic schizophrenic patients. Biol Psychiatr 1991; 30: 409-412.
71. Sinet P. M., Debray Q., Carmagnol F., Pelicier Y., Nicole A., Jerome H. Normal erytrocyte SOD values in two human diseases: Schizophrenia and cystic fibrosis. In: Greenwald R. A., Cohen G., eds. Oxy Radicals and their Scavenger Systems. Vol II: Cellular and Medical Aspects. New York: Elsevier Press, 1983; pp 302-304.
72. Stoklasova A., Zapletalek M., Kudrnova K., Randova Z. Glutathione peroxidase activity of blood in chronic schizophrenics. Sborniku Vedeckych Proci Lekarske Fakulty UK v Hradci Kralove 1986; 291-2: 103-108.
73. Buckman T. D., Kling A. S., Eiduson S., Sutphin M. S., Steinberg A. Glutathione peroxidase and CT scan abnormalities in schizophrenia. Biol Psychiatr 1987; 22: 1349-1356.
74. Buckman T. D., Kling A. S., Eiduson S., Sutphin M. S., Steinberg A., Eiduson S. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables. Psych Res 1990; 31: 1-14.
75. Glazov V. A., Mamzev V. P. Catalase in the blood and leucocytes in patients with nuclear schizophrenia. Zh Neuropatol Psikhiatr 1976; 4: 549-552.
76. Mukherjee S., Mahadik S. P., Scheffer R., Correnti E., Kelkar H. Impaired antioxidant defense at the onset of psychosis. Schizophr Res 1995; in press.
77. Mukherjee S., Mahadik S. P., Correnti E. E., Scheffer R. Early recurrence of psychosis after recovery from a first episode: Possible role of oxidative stress. Biol Psychiatr 1995; in press.
78. Wise C. D., Baden M. M., Stein L. Post-mortem measurement of enzymes of human brain: evidence of a central non-adrenergic deficit in schizophrenia. J Psychiatric Res 1974; 11: 185-198.
79. Brown J. S., Jr. Role of selenium and other trace elements in the geography of schizophrenia. .Schizophr Bull 1994; 20: 387-398.
80. Wyatt R. J. Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991; 17: 235-280.
81. Loebel A. D., Lieberman J. A., Alvir J. M. J., Mayerhoff D. I., Geisler S. H., Szymanski S. R. Duration of psychosid and outcome in first-episode schizophrenia. Am J Psychiatr 1992; 149: 1183-1188.
82. Szabo L., Lajko K., Barabas K., Matkovics B. Effects of neuroleptics on lipid peroxidation and peroxide metabolism enzyme activities in various discrete areas of the brain. Chem Pharmacol 1983; 14: 537-539.
83. Weinberger D. R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatr 1987: 44: 660-669.
84. Fish B., Marcus J., Hans S., Auerbach J. G., Perdue S. Infants at risk for schizophrenia: Sequelae of a genetic neurointegrative defect. Arch Gen Psychiatr 1992; 49: 221-235.
85. Bloom F. Comment: Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatr 1993; 50: 224-227.
86. Suddath R. L., Christison G. W., Torrey E. F., Casanova M. F., Weinberger D. R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia N Engl J Med 1990; 322: 789-794.
87. Banes F. M., Bird E. D. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatr 1987; 44: 608-616.
88. Akbarian S., Bunney W. E., Potkin S. G. et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development Arch Gen Psychiatr 1993; 50: 169-177.
89. Akbarian S., Vinuela A., Kim J. J., Potkin S. G., Bunney W. E., Jones E. G. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development Arch Gen Psychiatr 1993; 50: 178-187.
90. Mukherjee S., Reddy R., Schnur D. Developmental model of negative syndromes in schizophrenia In: Greden J., Tandon R., eds. Negative Schizophrenic Syndromes. Washington, DC: American Psychiatric Press, 1991; pp 175-185.
91. Shepherd R. A., Bates P. R., McGrath J. J. Cell cycle characteristics after ionising radiation induced DNA damage in schizophrenia. Biol Psychiatr 1993; 33: 60-61.
92. Mahadik S. P., Mukherjee S., Laev H., Reddy R., Schnur D. Abnormal growth and morphology of fibroblasts from schizophrenic patients. Psychiatr Res 1991; 37: 309-320.
93. Mahadik S. P., Wakade C. G., Scheffer R., Correnti E., Borison R. L., Mukherjee S. Abnormal growth of skin fibroblasts from drug-naive psychotic patients. Biol Psychiatr 1993; 33: 69A.
94. Mukherjee S., Mahadik S. P., Schnur D., Heljo L., Reddy R. Abnormal growth of cultured skin fibroblasts associated with poor premorbid history in schizophrenic patients. Schizophr Res 1994; 13: 233-237.
95. Freedman R., Stromberg I., Seiger A. et al. Initial studies of embryonic transplants of human hippocampus and cerebral cortex derived from schizophrenic women. Biol Psychiatr 1992; 32: 1148-1163.
96. Kaiya H., Nishida A., Imani A., Nakashima S., Nozawa Y. Accumulation of diacylglycerol in platelet phosphoinositide turnover in schizophrenia: A biological marker of good prognosis? Biol Psychiatr 1989; 26: 669-676.
97. Essali M. A., Das I., de Belletoche J., Hirsch S. R. The platelet polyphopshoinositide system in schizophrenia: The effects of neuroleptic treatment. Biol Psychiatr 1990; 28: 475-487.
98. Yao J. K., Yassaei P., van Kammen D. P. Increased turnover of of platelet phosphatidylinositol in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 1992; 46: 39-46.
99. Hudson C. J., Young L. T., Li P. P., Warsh J. J. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 1993; 13: 278-293.
100. Chang J., Musser J. H., McGregor H. Phospholipase A2: function and pharmacological regulation. Biochem Pharmacol 1987; 36: 2429-2436.
101. Vallar L., Meldolesi J. Mechanisms of signal transduction at the dopamine D2 receptor. Trends Pharmacol Sci 1987; 10: 74-77.
102. ++ mobilization in Xenopus oocytes. Proc Natl Acad Sci USA 1990; 87: 2196-2200.
103. Piomelli D., Pilon C., Giros B., Sokoloff P., Martres M.-P., Schwartz J.-C. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 1991; 353: 164-167.
104. Seeman P., Niznik H. B., Guan H-C., Booth G., Ulpian C. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc Natl Acad Sci USA 1989; 86: 10156-10160.
105. Braff D. L. Information processing and attention dysfunctions in schizophrenia. Schizophr Bull 1993; 19: 233-260.
106. Horrobin D. F., Glen A. I. M., Vaddadi K. S. The membrane hypothesis of schizophrenia. Schizophr Res 1994; 13: 195-208.
107. Suboticanec K., Folnegovic V., Korbar M., Mestrovic B., Buzina R. Vitamin C status in chronic schizophrenia. Biol Psychiatr 1990; 28: 959-966.
108. Beauclair L., Vinogradov S., Riney S. J., Csernansky J. G., Hollister L. E. An adjunctive role for ascorbic acid in the treatment of schizophrenia? J Clin Psychopharmacol; 1987; 7: 282-283.
109. Straw G. M., Bigelo L. B., Kirch D. G. Haloperidol and reduced haloperidol concentrations and psychiatric rating in schizophrenic patients treated with ascorbic acid. J Clin Psychopharmacol 1989; 9: 130-132.
110. Linday L. A., Pippenger C. E., Howard A., Lieberman J. A. Free radical scavenging enzyme activity and related trace metals in clozapine-induced agranulocytosis: A pilot study. J Clin Psychopharmacol 1995; 15: 353-360.
111. Aruoma O. I., Halliwell B. Superoxide-dependentand ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Biochem J 1987; 241: 273-278.
112. Sohal R. S., Ku H.-H., Agarwal S., Forster M. J., Lal H. Oxidative damage, mitochondrial oxidant generation, and antioxidant defenses during aging and in response to food resriction in the mouse. Mech Aging Dev 1994; 74: 121-133.
113. Masoro E. J. A critical review: Nutrition and aging - a current assessment. J Nutr 1984; 115: 842-448.
114. Sohal R. S., Sohal B. H., Brunk U. F. Relationship between antioxidant defenses and longevity in different mammalian species. Mech Aging Dev 1990; 53: 217-227.
115. Ku H.-H., Brunk U. T., Sohal R. S. Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. Free Radical Biol Med 1993; 15: 621-627
116. Allebeck P. Schizophrenia: a life-threatening disease. Schizophr Bull 1989; 15: 81-89.
117. Christinsen O., Christinsen E. Fat consumption and schizophrenia. Acta Psychiatr Scand 1988; 78: 587-591.